Status:

TERMINATED

Chloroquine Phosphate Against Infection by the Novel Coronavirus SARS-CoV-2 (COVID-19): The HOPE Open-Label, Non Randomized Clinical Trial

Lead Sponsor:

Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A.

Collaborating Sponsors:

Athens General Hospital Hippokrateio

Sotiria Thoracic Diseases Hospital of Athens

Conditions:

Pneumonia, Viral

Covid-19

Eligibility:

All Genders

18-90 years

Phase:

PHASE2

Brief Summary

This is an open label clinical study to evaluate the activity of chloroquine phosphate in patients with SARS-CoV-2 virus infection. The study aims to document possible prevention of pneumonia in patie...

Detailed Description

Humanity has been experiencing a new pandemic of the SARS Coronavirus-19 virus (SARS-CoV-2) since December 2019, causing the disease known as COVID-19. As of March 23, 2020, there have been 382,341 do...

Eligibility Criteria

Inclusion

  • Age 18 or older
  • Both genders
  • For women of childbearing age, they should use or be willing to use a double contraceptive method during the study. A urine pregnancy test to exclude pregnancy will be performed prior to study initiation.
  • Written consent after information provided by the patient or the legal representative in the event that the patient cannot consent.
  • Upper respiratory or lower respiratory tract infection, as in Annexes II and III respectively.
  • Positive respiratory secretion test for SARS-CoV-2 virus by molecular techniques or positive blood IgM titers.

Exclusion

  • Under 18 years of age
  • Denial of written consent
  • Any patient case where it has been decided not to rejuvenate
  • Serum AST values greater than 5 times the upper normal range
  • QTc interval in rest electrocardiogram greater than 500msecs
  • Pregnancy or lactation. Urgent pregnancy test to exclude pregnancy before inclusion in the study

Key Trial Info

Start Date :

April 6 2020

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

November 30 2020

Estimated Enrollment :

29 Patients enrolled

Trial Details

Trial ID

NCT04344951

Start Date

April 6 2020

End Date

November 30 2020

Last Update

September 23 2021

Active Locations (8)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (8 locations)

1

Divine Providence Hospital "Pammakaristos"

Athens, Greece, 11144

2

Athens General Hospital "Hippokrateio"

Athens, Greece, 11527

3

Athens General Hospital of Thoracic Diseases "SOTIRIA", 1st University Pulmonary Clinic

Athens, Greece, 11527

4

Athens General Hospital of Thoracic Diseases "SOTIRIA", 3rd University Pathology Clinic

Athens, Greece, 11527